Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Author's Avatar
Jan 05, 2022

%3Cb%3EBone+Biologics+Corporation%3C%2Fb%3E (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company’s president and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 –13, 2022. A pre-recorded presentation will be available beginning Monday, January 10 at 7:00 a.m. Eastern time. Interested parties may access a webcast of the presentation on the investor relations section of the Company’s website and at this link.